Navigation Links
MedImmune Announces Phase 2 Safety Data for Anti-RSV Antibody and National RSV Surveillance Results
Date:10/4/2007

irology Laboratory, Universidad Catolica de Chile,

-- Friday, October 5, 2007; 12:30 - 2:00 p.m. in Poster Halls G-H.

-- This study assessed the safety and immunogenicity of

motavizumab, an investigational anti-RSV MAb, in young children

with a history of prematurity who received two sequential

seasons of the antibody.

RSV Surveillance: Retrospective and Current Data on the Variance in Season Onsets and Offsets (Poster Presentation #719) - Jessie R. Groothuis M.D., MedImmune,

-- Saturday, October 6, 2007; 12:15 - 1:45 p.m. in Poster Halls G-H.

-- A nationwide active surveillance program was established to

evaluate the variability of the RSV season temporally and

geographically in the United States. Laboratory results from a

three-year period were analyzed by month and by geographic

region.

Additional information regarding the IDSA 45TH Annual Meeting can be found at http://www.idsociety.org/Meetingshome.aspx?id=238 .

MedImmune's Commitment to RSV Prevention

MedImmune is a world leader in the development of innovative therapeutic biologic products to prevent RSV disease. In 1996, MedImmune launched the first anti-RSV drug, RespiGam(R) (respiratory syncytial virus immune globulin intravenous (human) (RSV-IGIV)), which was a polyclonal antibody administered via four-hour intravenous infusion. In 1998, MedImmune introduced Synagis(R) (palivizumab), which was the first MAb to receive U.S. Food and Drug Administration (FDA) approval for an infectious disease. With the development of motavizumab, MedImmune continues to reinforce its commitment to developing anti-RSV products. In a head-to-head comparative Phase 3 trial with Synagis, motavizumab met its primary endpoint of reducing RSV-related hospitalizations in high-risk pe
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
5. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
6. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
9. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
10. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
11. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)...  University Hospitals (UH) Case Medical Center is ... area to implant a new miniaturized, wireless monitoring sensor to ... first and only FDA-approved heart failure monitoring device that has ... physicians to manage heart failure., The ... the pulmonary artery (PA) during a non-surgical procedure to directly ...
(Date:6/2/2015)... , June 2, 2015   PDI , ... today announced a series of corporate commitments designed ... to reduce the threat of antimicrobial-resistant microorganisms as ... Centers for Disease Control and Prevention (CDC) and ... to Combat Antibiotic-Resistant Bacteria. Along with ...
(Date:6/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/zkkg9q/blood_processing ) has announced ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , Latin America , and Rest of ... 2014 through 2020. Also, a seven-year historic analysis is provided ...
Breaking Medicine Technology:UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 2UH Case Medical Center becomes first in region to offer patients a new heart failure monitoring solution 3PDI Partners with White House and Centers for Disease Control and Prevention (CDC) to Combat Antimicrobial Resistance 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 2Blood Processing Supplies and Equipment Market - Global Strategic Business Report 2015-2020 3
... Bend Research Inc. ( www.bendres.com ), a leading independent ... has received a new U.S. patent covering a process ... pressure nozzles. The patent, which adds ... can be used to make solid amorphous dispersions with ...
... Inc. Magazine Tuesday ranked PercipEnz ... an exclusive ranking of the nation,s fastest-growing private ... at the most important segment of the economy—America,s ... 7-Eleven, Brooklyn Brewery, and Radio Flyer, maker of ...
Cached Medicine Technology:Bend Research Receives Patent for Preparing Spray-Dried Drug Dispersions Using Pressure Nozzles 2PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 2PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 3PercipEnz Makes Inc. Magazine's Fourth Annual List of America's Fastest-Growing Private Companies—the Inc. 5000 4
(Date:6/3/2015)... June 03, 2015 Fit Body Boot ... camp fitness program. The company helps thousands of individuals across ... encourage more people to hit the gym and get the ... tips for getting the most out any gym membership: , ... about committing to gym memberships is saying motivated and on ...
(Date:6/3/2015)... Veatch Consulting Services is excited to announce ... for business in April 2006, they have made it ... clients. Each and every year they have worked diligently ... to say that they are off to a great ... added this year is the Customer Review site veatchconsultingreviews.weebly.com. ...
(Date:6/3/2015)... evigilo, a world leader in delivering ... new branding by launching a new and enhanced content-centric ... identity: the logo depicting a sun-like image with a ... – To Know. To Act. In time. The color ... A global, borderless approach to alerting and delivering safety ...
(Date:6/2/2015)... 2015 The organic cotton market is ... an annual study conducted by Textile Exchange, an international ... The report, released today, encompasses extensive data about organic ... level and also takes the opportunity to celebrate those ... , The last several years have been complicated ...
(Date:6/2/2015)... 02, 2015 Aidan Booth And ... to public yesterday, and has since received rave ... product reviewer Tiffany Hendricks has weighed in with ... the course on her website HonestyFirstReviews.com. , "These ... Internet marketers looking to hone their business skills ...
Breaking Medicine News(10 mins):Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 2Health News:Summer Body Slim-Down: 5 Ways to Avoid Quitting Gym Memberships this Summer 3Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 2Health News:Veatch Consulting Services Is Breaking New Ground in Customer Satisfaction 3Health News:Keep calm! evigilos' "sun" will come out tomorrow – to know, to act, in time. 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 2Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 3Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 4Health News:Organic Cotton Market Sees 10% Growth Following Three Years of Decline 5Health News:100K Factory - Review of Aidan Booth and Steve Clayton's New IM System Published 2
... The Society of Nuclear Medicine (SNM) commends the U.S. ... System Drugs Advisory Committee on its recent recommendation for ... agent, which is used in conjunction with positron emission ... the brain which may cause Alzheimer,s disease, is produced ...
... address the latest issues on the early detection of ... will host an international research consortium in Scottsdale, Ariz., ... Program, or I-ELCAP, is a lung cancer research organization ... 26 states and eight other countries whose mission ...
... Michigan Cardiovascular Center and the University of Pittsburgh have been ... devices for the large and growing group of Americans with ... Blood Institute and HeartWare International, a maker of left ventricular ... these devices that support the circulation of patients with failing ...
... MONDAY, Jan. 24 (HealthDay News) -- There,s a much greater ... they score just below a round number (such as 1200) than ... Researchers analyzed a set of SAT scores from 1994 to 2001 ... This indicates that students who got those scores were more likely ...
... Jan. 23 (HealthDay News) -- Sledding is one of ... certain safety precautions are needed in order to prevent ... recent year in which sledding injury data was available ... injuries treated at U.S. hospital emergency rooms, doctors, offices ...
... survive and thrive in its hiding spot within the human immune ... remains such a formidable foe after three decades of research ... it also offers scientists a new, unexpected way to try to ... of Rochester Medical Center and Emory University was published Dec. 10 ...
Cached Medicine News:Health News:SNM applauds FDA advisory committee recommendation for approval of Alzheimer's imaging agent 2Health News:Biodesign hosts international consortium on screening for lung cancer 2Health News:Study examines earlier use of heart pumps in growing group of heart failure patients 2Health News:Study examines earlier use of heart pumps in growing group of heart failure patients 3Health News:For Safe Sledding, Follow These Tips 2Health News:Unexpected find opens up new front in effort to stop HIV 2
Lyphochek Benzo/TCA Control Set A is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and tricyclic antidepressant drugs....
Lyphochek Benzo/TCA Control Set B is ideal for monitoring HPLC methods for identification and quantitation of benzodiazepines and antidepressant drugs....
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels....
Lyphochek Endocrine Control is a human based product designed to monitor plasma catecholamine testing procedures by HPLC. The analytes are spiked at critical concentrations to cover the dynamic range...
Medicine Products: